Security key
98386D307
XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (XTLB)
CUSIP: 98386D307
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / SPONSORED ADR NE
- Total 13F shares
- 500,698
- Total 13F value
- $1,999,000
- Share change
- -7,803
- SEC-reported price per share
- $3.99
- Number of holders
- 5
- Value change
- -$29,157
- Number of buys
- 1
- Number of sells
- 3
Report period
Q2 2021
Institutions
5
Top holders
5
XTLB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
XTL BIOPHARMACEUTICALS LTD SEC filings
XTL BIOPHARMACEUTICALS LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98386D307
Recent filing periods:
Ownership snapshot
Top reported holders of XTLB - XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Noked Capital LTD
Disclosed value leader
Noked Capital LTD
Comparable rows
0/6
Latest evidence
31 Mar 2021
13F
Highest disclosed value: $662,000
6 rows are not safely comparable across share classes.
Quick read
Noked Capital LTD has the largest disclosed position value at $662K.
0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Noked Capital LTD's linked filing trail.
Disclosed position value
Top 5
Noked Capital LTD
$662K
Noked Israel Ltd
$662K
MORGAN STANLEY
$180K
RENAISSANCE TECHNOLOGIES LLC
$129K
SteelPeak Wealth, LLC
$48K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Noked Capital LTD |
13F
Company
|
—
denominator unverified
|
$662,000
198,888 shares
|
— | 31 Mar 2021 |
| Noked Israel Ltd |
13F
Company
|
—
denominator unverified
|
$662,000
198,888 shares
|
— | 31 Mar 2021 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$180,000
54,026 shares
|
— | 31 Mar 2021 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$129,000
38,800 shares
|
— | 31 Mar 2021 |
| SteelPeak Wealth, LLC |
13F
Company
|
—
denominator unverified
|
$48,000
14,375 shares
|
— | 31 Mar 2021 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$12,000
3,524 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
5
Shares
500,698
Rows available
5
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q4 2025 Across Filers
Q4 2025 holders
6
Q2 2021 holders
5
Holder diff
-1
| Investor | Q4 2025 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend